Road Communications to help launch asthma treatment in UK

Road Communications has won a brief to help a healthcare company take a share of the lucrative market for the treatment of respiratory diseases such as asthma.

Costly problem: Asthma affects five million people in the UK
Costly problem: Asthma affects five million people in the UK

Virginia Medical Supplies has called in Road to support the UK rollout of Salin Plus, a ventilator that disperses microscopic salt particles into the lungs and is designed to treat the causes of respiratory disease.

Road has been asked to explain the benefits of the therapy to clinicians. Other objectives are to create online educational assets, engagement programmes with key stakeholder groups, and deliver a media relations and social media launch programme.

The UK has more than five million asthma sufferers, among the highest in Europe. The condition is estimated to cost £1.2bn in lost productivity and £2bn a year for the NHS.

Salin Plus’ launch comes a year after the Government announced a fresh strategy to improve treatment for people with asthma and chronic obstructive pulmonary disease, as well as reducing the amount of time sufferers had to stay in hospital.

Virginia Medical Supplies claims it offers a gentler treatment than that provided by inhalers.

Salin Plus is currently only available at pharmacies in Australia, Ireland and Eastern Europe.

‘There is a growing body of evidence for this treatment,’ said Road MD Paul Jarman. ‘It has significant benefits in easing symptoms and offers adjunctive treatment to sufferers with chronic problems.’

The contract is initially for six months, with a view to renewal for a longer-term campaign.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Already registered?
Sign in